Miravirsen

DB12851InvestigationalProtein Based Therapies

Miravirsen has been investigated for the treatment of Hepatitis C and Hepatitis C, Chronic.

Code names
SPC3649

Resolves to

Compound
UNIIQ083AJW7VSCAS1072874-90-8
Targets
Q9NRR4DROSHAQ9UPY3DICER1

What you can answer from here — as of September 20, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Miravirsen, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In